SCI时时刷

search
Should All CAR-T Therapy for Acute Lymphoblastic Leukemia Be Consolidated with Allogeneic Stem Cell Transplant?
Available online 11 November 2022, 101414AbstractAutologous T cells genetically modified with a CD19 chimeric antigen rece...
Recent Progress in Acute Leukemia and Myelodysplasia
Leukemia represents 3.2% of all new cancer cases in the United States and will account for approximately 23,660 deaths in ...
COVID-19: A hematological perspective
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of c...
How can we improve response assessments in MDS? Strategies to improve response assessment in MDS treatment paradigms
Available online 26 October 2022, 101405AbstractEvaluating response to treatment in MDS represents a major challenge due t...
When Will Chemotherapy Be Replaced in Upfront Induction Therapy for Adult Acute Lymphoblastic Leukemia (ALL)?
Available online 26 October 2022, 101404AbstractThe treatment of acute lymphoblastic leukemia (ALL) has changed significan...
How Can We Incorporate Molecular Data into the IPSS?
Available online 1 November 2022, 101410Keywordsacute myeloid leukemiaAMLgenetic profilingInternational Prognostic Scoring...
Improving clinical trials in higher-risk myelodysplastic syndromes
Available online 28 October 2022, 101406AbstractPatients with higher risk myelodysplastic syndromes (HR-MDS) have poor sur...
Consolidation Chemotherapy in AML: Are We Playing with a Full Deck of Cards?
Available online 29 October 2022, 101408AbstractThe safe diminution of leukemic cell numbers to a level such that the pati...
Measurable Residual Disease in Acute Lymphoblastic Leukemia: How Low is Low Enough?
Available online 29 October 2022, 101407AbstractQuantification of measurable residual disease (MRD) in acute lymphoblastic...
COVID-19 disease and immune dysregulation
Available online 15 October 2022, 101401AbstractThe SARS-CoV-2 virus has complex and divergent immune alterations in diffe...
COVID-19 and antiphospholipid antibodies
Available online 15 October 2022, 101402AbstractAntiphospholipid syndrome and the coagulopathy of COVID-19 share many path...
Acute GVHD: new approaches to clinical trial monitoring
Available online 8 October 2022, 101400Highlights•Mount Sinai Acute GVHD International Consortium (MAGIC) has developed me...
COVID-19 and HSCT (Hematopoietic stem cell transplant)
Available online 8 October 2022, 101399AbstractHSCT recipients are at increased risk for COVID-19-associated morbidity and...
SARS-CoV-2 primary and breakthrough infections in patients with cancer: Implications for patient care
Available online 29 September 2022, 101384Highlights•Patients with cancer are at increased risk for COVID-19 and severe co...
A perspective on the sickle cell disease international COVID-19 registry
Available online 24 September 2022, 101385AbstractTo understand the risks and outcomes of COVID-19 in the sickle cell dise...
Update on diagnostic approaches and therapeutic strategies in systemic mastocytosis
Available online 14 September 2022, 101380AbstractSystemic mastocytosis is a rare disease which is being better recognized...
Vaccine-induced immune thrombotic thrombocytopenia
Available online 13 September 2022, 101381AbstractVaccine-induced immune thrombotic thrombocytopenia (VITT) is primarily a...
COVID-19 outcomes in sickle cell disease and sickle cell trait
Available online 7 September 2022, 101382AbstractThroughout the Coronavirus Disease 2019 (COVID-19) pandemic, understandin...
Accelerated and blast phase myeloproliferative neoplasms
Myeloproliferative neoplasms (MPN) have an inherent risk of transformation into blast phase (MPN-BP) or accelerated phase ...
Thrombosis and bleeding in hematological malignancy
Available online 16 June 2022, 101353AbstractVenous (VTE) and arterial (ATE) thromboemboli are a leading cause of morbidit...
Challenges of diagnosing and managing pre-fibrotic myelofibrosis: A case-based and practical approach
Available online 24 August 2022, 101378AbstractPre-Fibrotic Myelofibrosis is a frequently under-recognised entity that has...
Prevention and treatment of COVID-19 in patients with benign and malignant blood disorders
Available online 24 August 2022, 101375AbstractPatients with moderate to severe immunosuppression, a condition that is com...
Coagulopathy in COVID-19 and anticoagulation clinical trials
Available online 23 August 2022, 101377AbstractSevere acute respiratory disease coronavirus 2 (SARS-COV-2) first emerged i...
Dysregulation of Protein S in COVID-19
Available online 23 August 2022, 101376AbstractCoronavirus Disease 2019 (COVID-19) has been widely associated with increas...
Myeloproliferative neoplasms in adolescents and young adults
Available online 14 August 2022, 101374AbstractMyeloproliferative neoplasms (MPNs) are clonal stem cell disorders commonly...